DAIC

JUNE 11, 2024

In electrophysiology, innovation is king, but it is often incremental, and it almost always lacks rationale, comprehensive clinical documentation and relevance for hospitals that try to balance the increasing costs of new technology with increasing demand and reimbursement that just can’t keep pace. So, again, innovation is great.

Innovation 104

Innovation AFIB Technology Electrophysiology 104

Frontiers in Cardiovascular Medicine

JANUARY 16, 2024

Introduction Catheter ablation is an effective and safe strategy for treating atrial fibrillation patients. Nevertheless, studies on the long-term outcomes of catheter ablation in patients with dilated cardiomyopathy are limited. Among the catheter ablation group, 58.7% ( n  = 27) had persistent atrial fibrillation.

Atrial Fibrillation 64

Atrial Fibrillation Ablation Cardiomyopathy Heart Failure 64

DAIC

JULY 24, 2024

Volta Medical has announced it has entered into a Joint Development Agreement with GE Healthcare to enhance arrhythmia procedures with artificial intelligence (AI)-driven electrophysiology technologies. Our mission to combat complex heart rhythm diseases relies on optimizing interoperability. The company has obtained U.S.

Atrial Fibrillation 105

Atrial Fibrillation AFIB Ablation Technology 105

DAIC

JUNE 11, 2024

Patients suffering from heart rhythm disorders are now being successfully treated with robotic ablation procedures using this advanced technology, and Hospital Santa Maria della Pietà is the first hospital in Italy to adopt the cutting-edge Genesis Robotic Magnetic Navigation (RMN) system. “As

Heart Rhythm 81

Heart Rhythm Technology Electrophysiology Arrhythmia 81

HeartRhythm

APRIL 30, 2024

Ventricular tachycardia (VT) ablation in structural heart disease improves arrhythmia free survival. Procedural factors that influence these outcomes are not well described.

Arrhythmia 40

Arrhythmia Ablation Electrophysiology Outcomes 40

DAIC

DECEMBER 27, 2023

With the unveiling of the Genesis System, Baptist Health Lexington has become the first in Kentucky, and one of the first in the world, to provide the latest advancement in robotic technology to treat cardiac arrhythmias. “We Gery Tomassoni , Director of Electrophysiology at Baptist Health Lexington.

Technology 105

Technology Heart Disease Heart Rhythm Arrhythmia 105

HeartRhythm

APRIL 30, 2024

There is limited data regarding safety, electrophysiologic characteristics and arrhythmia substrate during ventricular tachycardia (VT) ablation in patients with prior aortic valve replacement (AVR).

Aortic valve 40

Aortic valve Electrophysiology Tachycardia Aortic 40

Frontiers in Cardiovascular Medicine

FEBRUARY 11, 2024

Despite the relative efficacy of ablation, the risk of AF recurrence is substantial, particularly in patients with persistent AF (perAF). At present we do not have any reliable intra-procedural electrophysiologic predictors of long-term success of AF ablation other than pulmonary vein isolation.

Pulmonary 64

Pulmonary Ablation Atrial Fibrillation Electrophysiology 64

Journal of the American Heart Association

DECEMBER 8, 2023

The primary end point was syncope recurrence, and the secondary end point was the reduction of the ventricular arrhythmia score during exercise testing. The primary end point was syncope recurrence, and the secondary end point was the reduction of the ventricular arrhythmia score during exercise testing.

Ablation 45

Ablation Tachycardia Electrophysiology Outcomes 45

HeartRhythm

DECEMBER 31, 2024

Notwithstanding many insightful observations, the electrocardiogram (ECG) arguably ignited the big bang in our understanding of cardiac arrhythmias. The development of electrophysiology (EP) studies through intravascular catheters provided the leap to verifying mechanisms, setting the stage for interventions.

Arrhythmia 45

Arrhythmia Bradycardia Electrocardiogram Electrophysiology 45

Circulation: Arrhythmia and Electrophysiology

JANUARY 29, 2024

Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:High-power short-duration ablation has shown impressive efficacy and safety for pulmonary vein isolation (PVI); however, initial efficacy results with very high power short-duration ablation were discouraging. rates between 90W and 50W.

Electrophysiology 76

Electrophysiology Atrial Fibrillation Pulmonary Ablation 76

Frontiers in Cardiovascular Medicine

FEBRUARY 26, 2025

BackgroundAtrial fibrillation (AF) is the most prevalent cardiac arrhythmia worldwide, posing significant health burdens. Pulsed field ablation (PFA) is an emerging non-thermal technique that is gaining traction due to the ability to selectively target myocardial cells and minimize damage to surrounding tissues.

Ablation 52

Ablation Atrial Fibrillation Research Electrophysiology 52

Circulation: Arrhythmia and Electrophysiology

APRIL 17, 2024

Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:Epicardial radiofrequency catheter ablation (RFCA) of idiopathic ventricular arrhythmias (VAs) originating from the left ventricular summit (LVS) is challenging because of the anatomic barriers.

Arrhythmia 45

Arrhythmia Ablation Electrophysiology Outcomes 45

HeartRhythm

MAY 8, 2024

Establishing the precise mechanism of cardiac arrhythmias in the electrophysiology laboratory is one of the main requisites for a successful and safe ablation.

Electrophysiology 40

Electrophysiology Laboratory Article Tachycardia 40

Frontiers in Cardiovascular Medicine

FEBRUARY 17, 2025

The standardized workflow included general anesthesia, a single transeptal puncture trough with a bidirectional, steerable visualizable sheath introduced into the left atrium accommodated a high density, penta-spline mapping catheter and a contact force sensor ablation catheter enabled to deliver vHPSD.

Atrial Fibrillation 52

Atrial Fibrillation Ablation Laboratory Electrophysiology 52

HeartRhythm

SEPTEMBER 5, 2024

Post-operative arrhythmias are most often transient and medically treated, but some patients may require electrophysiology study (EPS) and ablation.

Congenital Heart Disease 45

Congenital Heart Disease Ablation Congenital Heart Disease 45

Journal of Cardiovascular Electrophysiology

NOVEMBER 29, 2023

However, the incidence of ventricular arrhythmias (VAs) is high in this population, both in the acute and delayed phases after implantation. LVAD patients presenting VAs refractory to antiarrhythmic therapy and catheter ablation procedures are not rare. In such patients, treatment options are extremely limited.

Arrhythmia 75

Arrhythmia Heart Failure Ablation Outcomes 75

Circulation: Arrhythmia and Electrophysiology

MAY 8, 2024

Circulation: Arrhythmia and Electrophysiology, Ahead of Print.

Arrhythmia 40

Arrhythmia Electrophysiology Ablation Circulation 40

HeartRhythm

JANUARY 6, 2025

Pulsed field ablation (PFA) is a novel modality shown to be safe and efficient.1 1 PFA is conventionally used for pulmonary vein isolation (PVI), but interest has arisen in delivering linear lesions to the posterior wall2 and mitral isthmus.3 3 The durability of these lesion sets has not been well evaluated.

Electrophysiology 40

Electrophysiology Bicuspid/Mitral Arrhythmia Pulmonary 40

Journal of Cardiovascular Electrophysiology

DECEMBER 7, 2023

Abstract Radiofrequency (RF) ablation of intramural ventricular arrhythmias (VAs) may require advanced ablation techniques to achieve effective energy transfer to the targeted tissue. In this article, we provide a step-by-step guide on when and how to perform bipolar ablation of VAs.

Arrhythmia 40

Arrhythmia Ablation Article 40

Circulation: Arrhythmia and Electrophysiology

FEBRUARY 10, 2025

Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:It is difficult to identify patients with atrial fibrillation (AF) most likely to respond to ablation. There remains an urgent need to develop procedural predictors of long-term AF ablation success.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Physiology Arrhythmia 40

Journal of Cardiovascular Electrophysiology

JANUARY 31, 2024

Bipolar catheter ablation for highly refractory cardiac arrhythmia—does rate of success depend on arrhythmia origin? Abstract Introduction Despite rapid technological progress, some arrhythmias are still resistant to standard unipolar ablation.

Arrhythmia 40

Arrhythmia Ablation Technology Article 40

HeartRhythm

APRIL 30, 2024

Adult patients with repaired Tetralogy of Fallot (rTOF) have a high incidence of ventricular arrhythmias from an early age due to slowly conducting anatomic isthmuses (SCAI) between valves and scars or patches from the repair.

Electrophysiology 40

Electrophysiology Ablation Arrhythmia 40

Frontiers in Cardiovascular Medicine

JANUARY 21, 2025

Atrial fibrillation is the most prevalent arrhythmia with a lifetime risk of nearly 30%. Additional advantages include providing electrophysiology lab personnel with a lead-free working environment and avoiding radiation exposure for both patients and physicians. It has initially been performed with fluoroscopic catheter guiding.

Atrial Fibrillation 52

Atrial Fibrillation Quality of Life Ablation Electrophysiology 52

Journal of Cardiovascular Electrophysiology

OCTOBER 14, 2024

Abstract Background The formation of transmural lesions is necessary for the ablation of persistent atrial fibrillation (prAF). Ablation index (AI) and generator impedance drop (ID) predict lesion size but their correlation with long-term outcomes in prAF is not known. 013 (arrhythmia-free survival of 67% vs. 52%).

Arrhythmia 40

Arrhythmia Ablation Atrial Fibrillation Outcomes 40

Circulation: Arrhythmia and Electrophysiology

FEBRUARY 18, 2025

Circulation: Arrhythmia and Electrophysiology, Ahead of Print.

Atrial Fibrillation 40

Atrial Fibrillation Electrophysiology Arrhythmia Ablation 40

DAIC

MARCH 26, 2024

The most common arrhythmia, atrial fibrillation , will affect approximately 12.1 Leadless pacemakers are considered the future in the treatment of heart arrhythmias and have allowed many patients to live their lives with no visible evidence of a pacemaker or heart device," said Birgersdotter-Green.

Pacemaker 105

Pacemaker Heart Rhythm Arrhythmia Atrial Fibrillation 105

Circulation: Arrhythmia and Electrophysiology

DECEMBER 11, 2024

Circulation: Arrhythmia and Electrophysiology, Ahead of Print.

Ablation 40

Ablation Electrophysiology Arrhythmia Circulation 40

HeartRhythm

SEPTEMBER 23, 2024

Atrial fibrillation (AF) is the most common arrhythmia worldwide, with increasing prevalence resulting from improved awareness, increased life expectancy, and advances in detection technology.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Heart Rhythm Electrophysiology 40

Circulation: Arrhythmia and Electrophysiology

SEPTEMBER 25, 2024

Circulation: Arrhythmia and Electrophysiology, Ahead of Print.

Ablation 40

Ablation Electrophysiology Tachycardia Arrhythmia 40

Journal of Cardiovascular Electrophysiology

JANUARY 31, 2024

Abstract Introduction With the entry of pulsed-field ablation (PFA) into electrophysiology, new possibilities for ablation of different substrates such as epicardial foci of premature ventricular contractions (PVCs) from coronary venous system (CVS) have been opened.

Ablation 40

Ablation Electrophysiology Article Technology 40

Journal of Cardiovascular Electrophysiology

MARCH 4, 2024

ECG data during the clinical arrhythmia (ventricular tachycardia [VT], upper left figure) is analyzed with an artificial intelligence algorithm which identifies a probable location of the source of the arrhythmia (left ventricular anterolateral papillary muscle, lower left figure). cm, LVEF 50 ± 18%) and was similar to 28 controls.

Arrhythmia 40

Arrhythmia Ablation Tachycardia Atrial Fibrillation 40

Circulation: Arrhythmia and Electrophysiology

DECEMBER 19, 2024

Circulation: Arrhythmia and Electrophysiology, Ahead of Print. We investigate whether additional linear ablation from the superior vena cava to the right atrial septum and cavotricuspid isthmus ablation improves the rhythm outcome of patients with persistent AF undergoing cryoballoon PVI (Cryo-PVI).METHODS:In

Atrial Fibrillation 40

Atrial Fibrillation Ablation Arrhythmia Pulmonary 40

HeartRhythm

MAY 15, 2024

In the past decade, major advances were made in catheter ablation for arrhythmias and implantation of cardiac implantable electronic devices.1 1 Catheter ablation for atrial fibrillation (AF) and ventricular tachycardia (VT) has become the standard of care for many patients presenting with these arrhythmias.2–4

Electrophysiology 40

Electrophysiology Atrial Fibrillation Ablation Arrhythmia 40

Circulation: Arrhythmia and Electrophysiology

DECEMBER 16, 2024

Circulation: Arrhythmia and Electrophysiology, Ahead of Print. Patients were randomly assigned to either the PVI+SVC ablation group or the PVI-only group. CONCLUSIONS:The addition of SVC ablation to PVI did not enhance freedom from atrial tachyarrhythmia at 12 months, and it led to increased complications.

Ablation 40

Ablation Atrial Fibrillation Electrophysiology Pulmonary 40

Journal of Cardiovascular Electrophysiology

DECEMBER 10, 2024

Pulsed field ablation (PFA) may overcome the disadvantages of thermal energy and improve both ablation efficacy and safety. Objective We report the feasibility, safety, and clinical efficacy of focal monopolar PFA in patients with the origin of their atrial arrhythmia in the SVC.

Arrhythmia 40

Arrhythmia Ablation Pulmonary Tachycardia 40

Journal of Cardiovascular Electrophysiology

DECEMBER 23, 2024

ABSTRACT Background Idiopathic ventricular arrhythmias (VAs) arising from the left anterior fascicle (LAF) are uncommonly seen, and their characteristics still need to be sufficiently investigated. This study aimed to conclude these VAs' characteristics and explore efficient ablation strategies. in the middle- and distal-LAF group.

Ablation 40

Ablation Arrhythmia Article 40